by Jordana Choucair | Aug 16, 2022 | M&A
The Federal Trade Commission (FTC) released a policy paper warning states to avoid certificates of public advantage (COPAs) legislation. The agency said it has seen a “resurgence” of the laws in recent years, including those passed by state legislatures “with the...
by Jordana Choucair | Aug 16, 2022 | Mental Health
Project Health Minds – a nonprofit formed by business, health care, entertainment, and tech leaders to address the mental health crisis – is developing a playbook to guide companies in supporting employees’ mental health. Launched last year, the platform is...
by Jordana Choucair | Aug 16, 2022 | Payers
Oscar Health announced it will expand the reach of its Cigna + Oscar small business plans into the Philadelphia metropolitan area. Pending regulatory approval, the plans will be offered in five counties – Bucks, Chester, Delaware, Montgomery, and Philadelphia –...
by Jordana Choucair | Aug 15, 2022 | D.C. News
The House passed the Inflation Reduction Act, granting Medicare the authority to negotiate prescription drug prices and extending enhanced Affordable Care Act (ACA) subsides for three years. Under the legislation, Medicare could negotiate lower prices for 10 high-cost...
by Jordana Choucair | Aug 15, 2022 | Life Sciences
A Reuters analysis found that the median yearly price of 13 novel medicines the Food and Drug Administration approved for chronic conditions in 2022 is $257,000. The price is higher than a recent JAMA study, which found that the median annual price for 30 drugs last...
Recent Comments